{"id":143478,"date":"2026-07-08T13:00:16","date_gmt":"2026-07-08T07:30:16","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=143478"},"modified":"2026-07-08T13:00:23","modified_gmt":"2026-07-08T07:30:23","slug":"meghmani-organics-q1-results-2027-preview","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/meghmani-organics-q1-results-2027-preview\/","title":{"rendered":"Meghmani Organics Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target"},"content":{"rendered":"
<\/div>\n

Meghmani Organics CMP Rs.47. Q1 FY27E revenue Rs.528-608 Cr. PAT estimate Rs.6-7 Cr. 12-month target Rs.40-46.<\/em><\/p>\n

Meghmani Organics<\/a> Q1 Results FY27 is coming into focus as investors position ahead of the July-August 2026 results season, with Meghmani Organics shares trading at Rs.47 against a market capitalisation of Rs.1,209 Cr and a price-to-earnings multiple of Not meaningful. As a specialty chemicals name on the NSE and BSE, Meghmani Organics enters the Meghmani Organics Q1 Results FY27 print with the Street watching revenue momentum, margin trajectory and management commentary on FY27 guidance.<\/p>\n

This Meghmani Organics Q1 Results FY27 preview is built on a trailing-growth framework applied to the company’s Q1 FY26 base of Rs.630 Cr revenue and Rs.13 Cr net profit, using the most recent year-on-year growth signal from Q4 FY26. This Q1 prediction is a Uniresearch trailing-growth projection, not a formal analyst estimate, and should be read alongside the company’s own guidance once released.<\/p>\n

Get Free Investment Predictions and Meghmani Organics Research at Univest<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n